Differential regulation of chemokine gene expression by 15-deoxy-Δ12,14 prostaglandin J21,2

Journal of Immunology

Volumn 166, Issue 12, 2001, Pages 7104-7111

  Zhang, X ^a   Ji Ming Wang, ^a   Wang Hua Gong, ^a   Mukaida, N ^a   Young, H A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA 12,14 PROSTAGLANDIN J2; ANTIINFLAMMATORY AGENT; DELTA12 PROSTAGLANDIN J2; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHORBOL 13 ACETATE 12 MYRISTATE; RANTES; UNCLASSIFIED DRUG;

ARTICLE; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOREGULATION; LIGAND BINDING; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035876919     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.12.7104     Document Type: Article

References (35)

1. Nitric oxide and macrophage function
2. Chemokines, receptors, and their role in cardiovascular pathology
3. Essential involvement of interleukin-8 (IL-8) in acute inflammation
4. Cyclopentenone prostaglandins - New allies in the war on inflammation
5. The peroxisome proliferator-activated receptor (PPARγ) as a regulator of monocyte/macrophage function
6. The nuclear receptor PPARγ and immunoregulation: PPARγ mediates inhibition of helper T cell responses
7. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
8. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
9. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor (PPARγ) agonists
10. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
11. Peroxisome proliferator-activated receptor-γ activators inhibit IFN-γ-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells
12. Activation of PPARα or γ reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells
13. Activation of peroxisome proliferator-activated receptor γ does not inhibit IL-6 or TNF-α responses of macrophages to lipopolysaccharide in vitro or in vivo
14. Peroxisome proliferator-activated receptors, orphans with ligands and functions
15. Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
16. 2 is a ligand for the adipocyte determination factor PPARγ
17. PPARγ: An essential regulator of adipogenesis and modulator of fat cell function
18. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells
19. IL-18 is a potent coinducer of IL-13 in NK and T Cells: A new potential role for IL-18 in modulating the immune response
20. Identification of COUP-TFII as a peroxisome proliferator response element binding factor using genetic selection in yeast: COUP-TFII activates transcription in yeast but antagonizes PPAR signaling in mammalian cells
21. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
22. Role for peroxisome proliferator-activated receptor α in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells
23. 2 inhibits the β-integrin-dependent oxidative burst: Involvement of a mechanism distinct from PPAR ligation
24. 2 in activated murine macrophages
25. 2
26. Peroxisome proliferator-activated receptor γ-dependent repression of the inducible nitric oxide synthase gene
27. 2 inhibits multiple steps in the NF-κB signaling pathway
28. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways
29. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism
30. 2+-dependent production and release of IL-8 in human neutrophils
31. Regulation of interleukin-8 gene expression
32. Establishment of lipopolysaccharide-dependent nuclear factor κB activation in a cell-free system
33. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma
34. Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patients
35. 2 in vitro and in vivo